FPT Announces Strategic Partnership and Investment with Sumitomo and SBI Holdings
HANOI, Vietnam, April 22, 2025 /PRNewswire/ — FPT Corporation announced a strategic…
April 22, 2025
Onward Therapeutics Announces IMPD Approval for Its Subsidiary Emercell to Start Clinical Investigation of Allogeneic NK Cell Therapy OT-C001 in Combination with Rituximab
EPALINGES, Switzerland and PARIS, April 22, 2025 /PRNewswire/ — Onward Therapeutics SA,…